期刊文献+

埃索美拉唑联合莫沙必利治疗反流性食管炎的临床观察 被引量:7

Clinical observation of esomeprazole combined with mosapride in treatment of reflux esophagitis
下载PDF
导出
摘要 目的探讨埃索美拉唑联合莫沙必利治疗反流性食管炎的临床效果,以进一步指导临床治疗。方法选取本院收治的150例反流性食管炎患者进行研究,按照随机分组原则分为A、B、C 3组,每组各50例,A组患者采用单纯埃索美拉唑进行治疗,B组患者采用单纯莫沙必利进行治疗,C组患者采用埃索美拉唑联合莫沙必利进行治疗,观察和比较3组患者的治疗有效率。结果 A组患者治疗总有效率为78.0%,B组患者治疗总有效率为68.0%,C组患者治疗总有效率为88.0%,3组间差异有统计学意义(P<0.05),C组治疗效果最为显著。结论埃索美拉唑联合莫沙必利治疗反流性食管炎,临床效果显著,值得在临床推广应用。 Objective To investigate the clinical efficacy of esomeprazole combined with mosapride in the treatment of reflux esophagitis in order to further guide clinical treatment. Methods 150 patients with reflux esophagitis admitted to our hospital were selected and randomly divided into group A,group B and group C,with 50 cases in each group.Group A received single esomeprazole treatment,group B received single mosapride treatment,and group C received esomepra- zole combined with mosapride treatment.The treatment response rates of the three groups were observed and compared. Results The total treatment response rates of group A,group B and group C were 78.0%,68.0% and 88.0% respective- ly,with statistically significant difference among the three groups (P〈0.05),and the treatment effect of group C was the most remarkable. Conclusion Esomeprazole combined with mosapride shows significant clinical effect in the treatment of reflux esophagitis,it is worthy of clinical promotion and application.
出处 《中国当代医药》 2013年第29期72-73,共2页 China Modern Medicine
关键词 埃索美拉唑 莫沙必利 反流性食管炎 Esomeprazole Mosapride Reflux esophagitis
  • 相关文献

参考文献8

二级参考文献30

  • 1金伟森,李金锁,杨绍勃,金虎.慢性功能性便秘对老年人健康的影响及防治[J].武警医学,2004,15(7):506-509. 被引量:7
  • 2陆星华,张泰昌.反流性食管炎诊断及治疗指南(2003年)[J].中华消化内镜杂志,2004,21(4):221-222. 被引量:844
  • 3罗金燕 龚均.胃肠运动与疾病[M].西安:陕西科学技术出版社,1996.336.
  • 4Katz PO, Gnsberg GG, Hoyle PE, et al. Relationship between intragastric acid control and healing status in the treatment of moderate to Aliment Phamacol Ther, 2007, 25.
  • 5Heudebert GR, Marks R, Wilcox CM, et al. Choice of long-term strategy for the management of patients with severe esophagitis : accost-utility analysis [J]. Gastroenterology, 1997, 112(9): 1078-1086.
  • 6Gastell DO, Kahrilas PJ, Richter JE, et al. Esomeprazole (40 mg) compared with lansoprazole (30 rag) in the treatment of erosive esophgitis [J]. Am J Gastroenterol, 2002, 97(3): 575-583.
  • 7Labenz J, Naucler E, Eklund S. A comparison of esomeprazole 40 mg once daily for the healing of reflux esophagitis [ J]. Gut, 2003, 52(1): 241.
  • 8Miyamoto M, Haruma K, Takeuchi K, el al. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton inhibitor therapy [ J]. J Gastroenterol Hepatol, 2008, 23(5): 744-751.
  • 9Rohss K,Hasselgren G,Hedenstrom H.Effect of esomep razole 40 mg vs omeprazole 40 mg on 24 hour intragastric pH in patients with symp toms of gastroesophageal reflux disease[J].Dig Dis Sci,2002,47(5):954-958.
  • 10Ruth M, Hamelin B, Rohss K, et al. The effect of mosa-pride, a novel prokinetic, on acid reflux variables in patients with gastro-esophageal reflux disease [J]. Aliment Pharrnacol Ther, 1998, 12(1): 35-40.

共引文献180

同被引文献41

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部